Get started
Author

Kinuko Mitani

Observed name: Mitani, Kinuko
OpenAlex ID: A5110125362
[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan].
2005 · Shuichi Miyawaki, Nobuhiko Emi, et al. · PubMed · 15
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML
2025 · Yoshikazu Ikoma, Nobuhiko Nakamura, et al. · Leukemia · 14
PDF
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners
2026 · Kazuhisa Chonabayashi, Makoto Iwasaki, et al. · Leukemia · 7
PDF
HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cells
2025 · Fumi Nakamura, Yuka Nakamura, et al. · Leukemia Research · 4
Low Frequency ofBCL10 Gene Mutations in B-Cell Non-Hodgkin’s Lymphoma
2001 · Jiro Tadokoro, Yuichi Nakamura, et al. · International Journal of Hematology · 2
Darbepoetin alfa for the treatment of anemia in myelodysplastic syndromes: a post-marketing surveillance study in Japan
2026 · Yasuyoshi Morita, Yukie Tsuji, et al. · International Journal of Hematology
PDF
[Long-term remission with venetoclax plus azacitidine in acute myeloid leukemia with negative conversion of FLT3 companion diagnostic testing at relapse].
2026 · Satsuki Yoshihara, Takashi Toya, et al. · PubMed
Progress of Therapeutic Antibodies in the Treatment of Patients with Multiple Myeloma and Possible Impacts of Antibodies on the Evaluation of Response to the Treatment
2024 · Imai, Yoichi, Handa, Tomoyuki, et al. · Institutional Repositories DataBase (IRDB)
PDF
Strategy for Maintenance Therapy for Transplant-eligible and Non-eligible Patients with Multiple Myeloma
2023 · Imai, Yoichi, Handa, Tomoyuki, et al. · Institutional Repositories DataBase (IRDB)
PDF
Works count: 9
Citation count: 42
H-index: 4
I10-index: 2
Year
Topic
Type